AstraZeneca (AZNL)

12,440.00p
   
  • Change Today:
    -88.00p
  • 52 Week High: 12,880.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 43,796
  • Market Cap: £157,262m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-25 Interim 28,045.00 6,529.00 346.00¢ 103.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 40.1 0.3 +137% 280.00¢ 2.9%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,441.1 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 70.6 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.4 0.1 +242% 290.00¢ 2.1%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.0 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 58,155.23 18,286.22 675.58p 18.5 1.8 +10% 241.12p 0.0%
31-Dec-26 61,705.13 20,673.83 766.71p 16.3 1.2 +14% 253.87p 0.0%
31-Dec-27 65,213.12 22,525.60 850.86p 14.7 1.3 +11% 265.85p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.06

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,440.00p
Change Today -88.00p
% Change -0.70 %
52 Week High 12,880.00p
52 Week Low 9,642.00p
Volume 43,796
Shares Issued 1,264.16m
Market Cap £157,262m

What The Brokers Say

Strong Buy 9
Buy 13
Neutral 4
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 24-Oct-2025

Time Volume / Share Price
11:18 23 @ 12,440.00p
11:17 40 @ 12,440.00p
11:17 38 @ 12,442.00p
11:16 33 @ 12,442.00p
11:16 41 @ 12,444.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page